OFFICIAL PUBLICATION OF

by its subsidiary APPco

Arthritis drug shortage looms

David Rowley 16/07/2021

TGA working with wholesalers to restrict available Actemra stock to community pharmacies and hospitals as stocks dwindle Australia faces a shortage of arthritis drug Actemra (tocilizumab) following recommendation by the World Health Organisation as treatment for patients seriously ill COVID-19. Shortages of some iterations of the interleukin-6 (IL6) receptor blocker class drug may, in some

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Arthritis drug shortage looms

Previous Clinical tips: Self-diagnosed thrush

Next The children's asthma conundrum

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Clinical tips: Self-diagnosed thrush

Next The children's asthma conundrum

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.